Skip to main content

Table 4 Distribution of drug resistance and VF genes among ESBL producers and non ESBLUPEC

From: Phylogeny, sequence-typing and virulence profile of uropathogenic Escherichia coli (UPEC) strains from Pakistan

Numbers and percentages of the isolates andtheir respective traits
Resistance traits All isolates (n = 155); n(%) Non ESBL producers (n = 90) n(%) ESBL producers (n = 65) n(%) p value
Piperacillin tazobactam 7(5) 4(4) 3(5) > 0.9999
Ceftazidime 96(62) 36(40) 60(92) < 0.0001
Cefotaxime 101(65) 40(44) 61(94) < 0.0001
Ceftriaxone 99(64) 49(54) 50(77) 0.0040
Ciprofloxacin 95(61) 45(50) 50(77) 0.000684
Levofloxacin 97(63) 48(53) 49(75) 0.0051
Amikacin 7(5) 4(4) 3(5) 0.9597
Gentamicin 47(30) 30(33) 17(26) 0.3373
Amoxicillin-clavulanic acid 111(72) 50(56) 61(94) < 0.0001
Trimethoprim sulfonamides 130(84) 67(74) 63(97) 0.0002
Nitrofurantoin 9(6) 6(7) 3(5) 0.5900
Fosfomycin 15(10) 8(9) 7(11) 0.6960
fimH 155 (100) 90 (100) 65 (100) > 0.9999
papA 20 (13) 12 (13) 8 (12) 0.8509
papC 75 (48) 42 (47) 33 (51) 0.6140
papEF 37 (24) 18 (20) 19 (29) 0.1834
papGI 6 (4) 3 (3) 3 (5) 0.6831
papGII 70 (45) 33 (37) 37 (57) 0.0124
papGIII 6 (4) 4 (4) 2 (3) 0.6632
sfa/foc 20 (13) 11 (12) 9 (14) 0.7660
Afa 15 (10) 7 (8) 8 (12) 0.3466
bmaE 2 (1) 1 (1) 1 (2) 0.8246
fyuA 37 (24) 20 (22) 17 (26) 0.5710
iutA 86 (55) 45 (50) 41 (63) 0.1060
feoB 76 (49) 40 (44) 36 (55) 0.1788
kpsmtII 40 (26) 19 (21) 21 (32) 0.1160
kpsmtIII 4 (3) 2 (2) 2 (3) 0.4729
Usp 22 (14) 10 (9) 12 (18) 0.1957
hlyA 18 (12) 7 (8) 11 (17) 0.0795
cdtB 11 (7) 6 (7) 5 (8) 0.8062
  1. Distribution of resistance and virulence traits among ESBL and non-ESBL producing uropathogenic E. coli (N = 155). The p values were calculated by comparing different traits among ESBL producer’s and non-ESBL producers